Parallax Volatility Advisers, L.P. Agenus Inc Call Options Transaction History

Parallax Volatility Advisers, L.P.

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$2.35 - $3.47 $646,250 - $954,250	-275,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.56 - $5.49 $704,000 - $1.51 Million	275,000 New	275,000 $1.51 Million
Q4 2019 Feb 14, 2020	SELL	$2.41 - $4.4 $54,225 - $99,000	-22,500 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.17 - $3.14 $48,825 - $70,650	22,500 New	22,500 $58,000
Q1 2019 May 15, 2019	SELL	$2.51 - $3.73 $94,124 - $139,875	-37,500 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.59 - $2.66 $59,625 - $99,750	37,500 New	37,500 $89,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.